Hallucinogens in Mental Health Treatment: Drug Pipeline Updates
Hallucinogens in mental health are increasingly being investigated in the drug pipeline, especially for depressive disorders and PTSD.
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hallucinogens in mental health are increasingly being investigated in the drug pipeline, especially for depressive disorders and PTSD.
28.05.2024 - NEW HAVEN, Conn., May 28, 2024 (GLOBE NEWSWIRE) - BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience and immuno-oncology, today announced ... Seite 1
NEW YORK, May 28, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,
Press release - Getnews - First Choice Chiropractic: Leading Excellence in Holistic Wellness - published on openPR.com
Brensocatib is an oral, reversible inhibitor of dipeptidyl peptidase 1.